A Seigneurin

Summary

Affiliation: CHU de Grenoble
Country: France

Publications

  1. doi request reprint Multifocality as a prognostic factor in breast cancer patients registered in Danish Breast Cancer Cooperative Group (DBCG) 1996-2001
    L E Joergensen
    Danish Breast Cancer Cooperative Group, Section 2501, Blegdamsvej 9, DK 2100 Kbh Ø, Denmark
    Breast 17:587-91. 2008
  2. doi request reprint Artefact-free trends in breast cancer incidence over two decades in a whole French Département
    Arnaud Seigneurin
    Hospices Civils de Lyon, Service de Biostatistiques, Lyon F 69424, France
    Breast 17:580-6. 2008
  3. doi request reprint Comparison of interval breast cancer rates for two-versus single-view screening mammography: a population-based study
    A Seigneurin
    Registre du Cancer de l Isère, 23 Chemin des Sources, Meylan, France
    Breast 18:284-8. 2009
  4. doi request reprint Association of diagnostic work-up with subsequent attendance in a breast cancer screening program for false-positive cases
    Arnaud Seigneurin
    Registre du Cancer de l Isère, Centre Hospitalier Universitaire de Grenoble, BP 217, Pavillon E, 38043 Grenoble Cedex 9, France
    Breast Cancer Res Treat 127:221-8. 2011
  5. pmc Overdiagnosis from non-progressive cancer detected by screening mammography: stochastic simulation study with calibration to population based registry data
    Arnaud Seigneurin
    Registre du Cancer de l Isère, Centre Hospitalier Universitaire de Grenoble, BP 217, Pavillon E, 38043 Grenoble Cedex 9, France
    BMJ 343:d7017. 2011
  6. doi request reprint Analysis of the effect of age on the prognosis of breast cancer
    C Cluze
    Cancer Registry of Isère, Meylan, France
    Breast Cancer Res Treat 117:121-9. 2009

Collaborators

Detail Information

Publications6

  1. doi request reprint Multifocality as a prognostic factor in breast cancer patients registered in Danish Breast Cancer Cooperative Group (DBCG) 1996-2001
    L E Joergensen
    Danish Breast Cancer Cooperative Group, Section 2501, Blegdamsvej 9, DK 2100 Kbh Ø, Denmark
    Breast 17:587-91. 2008
    ..The prognostic influence of multifocality in breast cancer patients. Breast 2004;13:188-193]...
  2. doi request reprint Artefact-free trends in breast cancer incidence over two decades in a whole French Département
    Arnaud Seigneurin
    Hospices Civils de Lyon, Service de Biostatistiques, Lyon F 69424, France
    Breast 17:580-6. 2008
    ..At most, the increase due to screening would reach 50%. In women aged 70-84, no real incidence increase was suspected if we assume that changes in clinical practices and screening led to more breast cancer cases collected...
  3. doi request reprint Comparison of interval breast cancer rates for two-versus single-view screening mammography: a population-based study
    A Seigneurin
    Registre du Cancer de l Isère, 23 Chemin des Sources, Meylan, France
    Breast 18:284-8. 2009
    ..To determine whether the implementation of two-view mammography was followed by a reduction in the rates of interval cancers...
  4. doi request reprint Association of diagnostic work-up with subsequent attendance in a breast cancer screening program for false-positive cases
    Arnaud Seigneurin
    Registre du Cancer de l Isère, Centre Hospitalier Universitaire de Grenoble, BP 217, Pavillon E, 38043 Grenoble Cedex 9, France
    Breast Cancer Res Treat 127:221-8. 2011
    ....
  5. pmc Overdiagnosis from non-progressive cancer detected by screening mammography: stochastic simulation study with calibration to population based registry data
    Arnaud Seigneurin
    Registre du Cancer de l Isère, Centre Hospitalier Universitaire de Grenoble, BP 217, Pavillon E, 38043 Grenoble Cedex 9, France
    BMJ 343:d7017. 2011
    ....
  6. doi request reprint Analysis of the effect of age on the prognosis of breast cancer
    C Cluze
    Cancer Registry of Isère, Meylan, France
    Breast Cancer Res Treat 117:121-9. 2009
    ..Our findings suggest that when taking into account grade and stage, the time-varying impact of young age at diagnosis is limited to grade 3 tumors, without evidence of worst prognosis at 5 years for the youngest women...